Sarah Doshna is the Director of Clinical Supply Manufacturing for sterile products at Bristol Myers Squibb. She came to BMS from Merck in 2003 to start the parenteral manufacturing group on the New Brunswick, New Jersey site. Her experience includes pilot scale facility and process design, equipment specification, clinical lot manufacture, technology transfer and final dosage pilot plant operations for biologics, peptides, and conventional small molecule pharmaceuticals. Doshna earned her Bachelor’s degree in chemical engineering from Johns Hopkins University and is a licensed Professional Engineer.